BNP Paribas Arbitrage SNC lowered its holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 58.3% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 71,296 shares of the biotechnology company’s stock after selling 99,600 shares during the period. BNP Paribas Arbitrage SNC owned approximately […]